Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synergia
Calgary, Alberta, Canadasynergiaenergy.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Synergia Biotech has developed an energy-efficient microbial process that uses cyanobacteria to convert sunlight and CO₂ into biomass, which is then processed to extract high-quality, all-natural blue pigment—phycocyanin. This product serves as a climate-friendly alternative to synthetic blue dyes in food, beverage, health/wellness, and personal care sectors. The process also contributes positively by mitigating CO₂ emissions. No clinical trial results are relevant since this is not a pharmaceutical pipeline.
- Therapeutic areas
- Other
- Modalities
- ProteinNatural Pigment
- Industry
- Non-Drug Biotech
02
Partnerships
Creative Destruction Lab
Beyond the preview
Go deeper on Synergia.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Synergia.